Pfizer Inc., Groton, CT

Process development and engineering of several late-stage drug candidates: ARV-471 (Vepdegestrant), Ibuzatrelvir, Sisunatovir, Etrasimod, and  Mevrometostat


Indiana University, Bloomington, IN

    Fluorination development via radical pathways.


University of Houston, Houston, TX

    C–C bond coupling enabled by organoboronates.


Bach Khoa University, HCM City, Vietnam

   Co-MOFs for applications in heterogeneous catalysis.